Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenofovir Alafenamide vs Tenofovir Disoproxil Fumarate for HBV Prophylaxis in Hematologic Malignancies
NCT06221657Phase 4Not yet recruiting
- Sponsor
- Yonsei University
- Start
- Feb 2024
- Primary completion
- Dec 2026
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of tenofovir alafenamide in hepatitis B (HBV), sponsored by Yonsei University. Planned start Feb 2024; status: not yet recruiting.
02
Drugs
tenofovir alafenamide
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT06221657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06221657.